Latest news for no rx panmycin

Average Rating: 5 out of 5 based on 150 user reviews.

In previous articles, “” and “”, we analyzed the “buy” recommendations of the analysts. no rx panmycin In this article we analyze the “sell” recommendations of the analysts. It’s generally not the aim of the analysts to recommend positions for going short, but it might be interesting to see how good the analysts are at getting out of positions. The analysts’ “going long” philosophy makes sense, as it is possible to make huge returns with long positions no rx panmycin, as the largest return possible with a short position is 100%, double your money. For this analysis, the buy recommendations of the analysts were ignored except for exiting previous “sell” recommendations. As in the previous articles, the results of this analysis include only stocks listed on the Nasdaq, NYSE and American stock exchanges going back to February of 1998 and does not include stocks that have merged, have been purchased, de-listed or have gone bankrupt. The results of the analysis are show below: ( are shown as links)

Analyst Start Date End Date Best Pick Best Pick % Ret. Worst Pick Worst Pick % Ret. No rx panmycin #co. 's Covered % Correct Avg % Ret.
AG Edwards Mar-98 May-06 86% -2585% 119 37% -72%
BB&T Capital Mkts Feb-03 May-06 CENF 78% -158% 30 47% -7%
Banc of America Sec Aug-00 Jun-06 68% -582% 151 39% -21%
Bear Stearns Jun-99 Jun-06 69% -1206% 149 36% -38%
Bernstein May-01 Mar-06 45% -524% 26 27% -68%
Brean Murray Jan-03 Jun-06 59% -125% 24 46% -10%
CIBC World Market Jun-99 Jun-06 95% -811% 193 37% -45%
Citigroup Aug-05 May-06 40% -77% 69 49% -4%
Credit Suisse May-99 Jun-06 PME 87% -637% 213 37% -31%
DA Davidson Dec-02 Jun-06 37% -119% 50 38% -12%
Deutsche Securities Jun-02 Jun-06 DCN 96% -227% 128 30% -31%
First Albany Sep-02 Jun-06 SCON 93% -163% 38 34% -20%
Friedman Billings May-00 Jun-06 65% -158% 80 45% -12%
Goldman Sachs Dec-98 Jun-06 MAG 80% ETP -705% 210 34% -29%
Harris Nesbitt Apr-04 Apr-06 90% -45% 39 59% 0%
J. P. Morgan Jun-01 Jun-06 83% -456% 364 29% -31%
JMP Securities Feb-03 Jun-06 69% -103% 48 40% -17%
Janney Montgomery Jun-98 May-06 45% -196% 24 46% -14%
Jefferies Apr-98 Jun-06 XIDE 76% AX -329% 89 44% -17%
Keefe Bruyette Mar-01 Jun-06 63% -270% 48 40% -16%
KeyBanc Capital Mkts / McDonald Oct-04 Jun-06 58% -139% 26 50% -5%
Lehman Brothers Jun-99 Jun-06 96% -333% 209 31% -30%
Matrix Research Dec-05 Jun-06 33% -168% 67 63% 1%
Merrill Lynch Apr-98 Apr-06 85% -499% 182 35% -38%
Moors and Cabot Apr-04 Feb-06 36% -82% 26 65% 0%
Morgan Keegan Jul-02 May-06 44% ATSI -900% 26 35% -51%
Morgan Stanley Sep-00 Jun-06 MANU 71% -1085% 307 30% -42%
Needham Nov-98 May-06 61% -484% 23 52% -35%
Oppenheimer Mar-04 May-06 SKYF 15% -49% 20 25% -10%
Piper Jaffray Aug-98 Jun-06 71% -329% 56 52% -5%
Prudential Aug-00 Jun-06 76% -2181% 209 34% -39%
RBC Capital Mkts Nov-01 May-06 SMRA 96% -1654% 153 29% -59%
Robert W. Baird Dec-99 May-06 96% -834% 62 34% -32%
Ryan, Beck & Co. Oct-02 May-06 33% -304% 26 46% -30%
Sandler O'Neill Oct-04 May-06 40% -329% 24 63% -23%
Stanford Dec-04 Jun-06 INCX 65% -72% 20 65% 2%
Stifel Nicolaus Aug-04 Jun-06 80% FRT -125% 20 50% -6%
Sun Trust Rbsn Humphrey Apr-02 Jun-06 89% -604% 30 47% -31%
Thomas Weisel Jun-03 May-06 GLGC 71% -156% 29 31% -21%
UBS Sep-03 Jun-06 78% -704% 170 37% -22%
WR Hambrecht Jul-02 Feb-06 ALT 90% -179% 20 30% -42%
Wachovia Feb-02 Jun-06 81% -586% 120 39% -29%
Wedbush Morgan Jan-03 Mar-06 56% -452% 20 30% -41%
The best analysts for recommending a sell appear to be the analysts at Stanford and at Matrix Research, both analysts exhibiting positive returns when following their sell recommendations. Also, from this analysis, it appears investors might experience better returns by buying when the some of the analysts recommend a “sell” and selling when some of the analysts recommend a “buy”. For example, the analyst AG Edwards had an average return of 51% in the previous [no rx panmycin] “buy” analysis article, but for the “sell” analysis AG Edwards exhibited a –72% return. But if the trades had been reversed, buying when AG Edwards recommended selling and selling when AG Edwards recommended buying, an investor would have experienced a positive 72% return instead of a negative 72% return, representing a superior return than buying when AG Edwards recommends buying and selling when AG Edwards recommends selling. Other analysts besides AG Edwards also included in the distinguished “contrarians” group include Bernstein, WR Hambrecht, Wedbush Morgan, RBC Capital Mkts, Needham, Thomas Weisel, Sandler O’Neill, CIBC World Market, Oppenheimer, and Robert W. Baird. For seeking a for "going short", there are several strategies available, and for example. provides a search engine for finding potential generating positions for various strategies for those option investors seeking to “go short”. [tags]Stock Analysts, Contrarian Stock Trading, Option Income, Option Investors, Stock Market Research, Optionable Stocks[/tags]


?? 2008-2016 Legit Express Chemist.